Total Payments
$6,268
2024 Payments
$2,252
Companies
25
Transactions
339
Medicare Patients
20,690
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$6,253 (99.8%)
Education$15.27 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,253 | 338 | 99.8% |
| Education | $15.27 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,367 | 75 | $0 (2024) |
| Janssen Biotech, Inc. | $641.14 | 33 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $594.14 | 28 | $0 (2024) |
| UCB, Inc. | $527.74 | 32 | $0 (2024) |
| LEO Pharma Inc. | $386.57 | 16 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $323.68 | 19 | $0 (2024) |
| Dermavant Sciences, Inc. | $316.36 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $303.64 | 16 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $284.13 | 16 | $0 (2024) |
| Amgen Inc. | $258.01 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,252 | 122 | ABBVIE INC. ($418.13) |
| 2023 | $2,092 | 112 | AbbVie Inc. ($402.57) |
| 2022 | $1,272 | 66 | ABBVIE INC. ($254.82) |
| 2021 | $391.05 | 23 | AbbVie Inc. ($127.65) |
| 2020 | $115.90 | 7 | AbbVie Inc. ($79.75) |
| 2019 | $49.52 | 3 | AbbVie, Inc. ($49.52) |
| 2018 | $34.57 | 2 | AbbVie, Inc. ($34.57) |
| 2017 | $60.63 | 4 | Allergan Inc. ($60.63) |
All Payment Transactions
339 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: DERMATOLOGY | ||||||
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/15/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $33.00 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.56 | General |
| Category: Immunology | ||||||
| 12/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Immunology | ||||||
| 12/04/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: DERMATOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.88 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Immunology | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.71 | General |
| Category: Immunology | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.66 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Dermatology | ||||||
| 11/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug), DUOBRII, TARGRETIN | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $21.38 | General |
| 10/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 5,776 | 9,112 | $1.0M | $352,846 |
| 2022 | 29 | 5,407 | 8,541 | $1.0M | $376,082 |
| 2021 | 24 | 5,009 | 7,529 | $864,911 | $335,340 |
| 2020 | 24 | 4,498 | 6,965 | $770,818 | $295,473 |
Total Patients
20,690
Total Services
32,147
Medicare Billing
$1.4M
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,876 | 2,413 | $401,714 | $137,359 | 34.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 1,109 | 1,407 | $175,678 | $57,801 | 32.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 293 | 309 | $65,331 | $23,042 | 35.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 291 | 291 | $60,136 | $20,500 | 34.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 474 | 637 | $44,298 | $17,693 | 39.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 238 | 256 | $48,428 | $16,998 | 35.1% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 38 | 48 | $34,758 | $14,010 | 40.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 736 | 2,819 | $35,180 | $13,912 | 39.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 83 | 92 | $30,462 | $10,875 | 35.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 180 | 194 | $20,242 | $7,247 | 35.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 60 | $14,131 | $4,458 | 31.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 46 | 47 | $12,950 | $4,419 | 34.1% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 38 | 46 | $12,002 | $4,063 | 33.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 14 | 14 | $7,956 | $3,274 | 41.2% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 55 | 55 | $9,371 | $3,178 | 33.9% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 20 | 22 | $7,386 | $2,817 | 38.1% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 20 | 20 | $6,199 | $2,445 | 39.4% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 19 | 19 | $6,686 | $2,290 | 34.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 32 | 41 | $3,851 | $1,572 | 40.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 39 | 39 | $5,140 | $1,503 | 29.2% |
| 69100 | Biopsy of ear | Office | 2023 | 21 | 21 | $3,785 | $1,434 | 37.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 12 | 12 | $2,717 | $1,114 | 41.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 42 | $1,084 | $387.37 | 35.7% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 27 | 30 | $717.22 | $265.63 | 37.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 22 | 162 | $323.72 | $119.01 | 36.8% |
About Dr. Maria Bogaert, M.D
Dr. Maria Bogaert, M.D is a Dermatopathology healthcare provider based in Winchester, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790756534.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maria Bogaert, M.D has received a total of $6,268 in payments from pharmaceutical and medical device companies, with $2,252 received in 2024. These payments were reported across 339 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($6,253).
As a Medicare-enrolled provider, Bogaert has provided services to 20,690 Medicare beneficiaries, totaling 32,147 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Other Specialties Clinical & Laboratory Dermatological Immunology, Procedural Dermatology
- Location Winchester, VA
- Active Since 01/30/2006
- Last Updated 08/23/2019
- Taxonomy Code 207ND0900X
- Entity Type Individual
- NPI Number 1790756534
Products in Payments
- SKYRIZI (Biological) $774.39
- Sotyktu (Drug) $556.92
- RINVOQ (Biological) $493.44
- TREMFYA (Drug) $465.70
- DUPIXENT (Biological) $389.24
- ADBRY (Biological) $325.56
- VTAMA (Drug) $316.36
- Cimzia (Drug) $288.13
- Bimzelx (Biological) $239.61
- COSENTYX (Drug) $200.84
- EUCRISA (Drug) $188.97
- REMICADE (Biological) $175.44
- Enbrel (Biological) $130.39
- Otezla (Drug) $127.62
- SILIQ (Drug) $127.19
- TALTZ (Drug) $125.99
- OPZELURA (Drug) $119.54
- ILUMYA (Biological) $118.10
- Winlevi (Drug) $116.43
- Humira (Biological) $84.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.